IL-17 was first discovered for its effects on synoviocytes from patients with rheumatoid arthritis [37], and later it was found to be involved in eliminating pathogens like gram-positive Propionibacterium acne, gram-negative Citrobacter rodentium, and fungi such as Candida albicans [38]. The gene discussed is IL17A; the disease is rheumatoid arthritis.